Aquapharm Biodiscovery (United Kingdom) a preclinical-stage discovery and development company focused on a marine based platform for the identification antimicrobial compounds, closed a $6.4M Series C financing. Participants include Aescap Venture, Tate & Lyle Ventures, Highlands and Islands Enterprise and NESTA.